Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Corcept Therapeutics
Age
18–65
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Be healthy
Have a BMI of 18 to 32 kg/m2, inclusive and body weight more than 50 kg (110 pounds)
Be judged to be in good health, based on the results of medical history, physical examination, vital signs, 12-lead ECG, and clinical laboratory findings
Have suitable veins for multiple venipuncture/cannulation
You may not be if
Have multiple drug allergies, or be allergic to any of the components of mifepristone or itraconazole
Have a condition that could be aggravated by glucocorticoid blockade (eg, asthma, any chronic inflammatory condition)
In the 1 year before study drug administration, have a history of drug or alcohol abuse
In the 6 calendar months before study drug administration, on average
* Have smoked more than 5 cigarettes/day
* Have consumed more than 21 units of alcohol/week (1 unit/drink = 5 ounces of wine, or 12 ounces of beer, or 1.5 ounces of hard liquor)
In 2 months prior to study drug administration, have donated/lost blood or plasma in excess of 400 mL
In the 30 days before study drug administration, have participated in another clinical trial of a new chemical entity or a prescription medicine
Clareo Health | Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor
